Counselors in Pearl Harbor, HI Accepting Medicare

7 Counselors found. Showing 1 - 7

Mr. James J Jones, LCDC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 480 Central Ave, Pearl Harbor, HI 96860 Phone: 737-297-0274

Noah Max Epstein Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 480 Central Avenue, Naval Health Clinic Pearl Harbor, Pearl Harbor, HI 96860 Phone: 808-474-4242

Classie Mejia, CSAC, ADCII Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 480 Central Ave, Pearl Harbor, HI 96860 Phone: 808-824-2648

Mariam Beshara, LPC., PSYD Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 480 Central Ave, Pearl Harbor, HI 96860 Phone: 808-473-0822

Mr. Cleveland Timothy Mcqueen Jr. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 480 Central Ave, Pearl Harbor, HI 96860 Phone: 808-473-0650

Robin S Oania, MA, CSAC, ICSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1253 Makalapa Gate Rd, Pearl Harbor, HI 96860 Phone: 808-389-3555

Mrs. Caroline Marie Crandall, RN Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1253 Makalapa Gate Rd, Pearl Harbor, HI 96860 Phone: 808-473-1880

News Archive

Young stem/progenitor cells improve health and life of progeria mice

Mice bred to age too quickly seemed to have sipped from the fountain of youth after scientists at the University of Pittsburgh School of Medicine injected them with stem cell-like progenitor cells derived from the muscle of young, healthy animals.

Study emphasizes benefits of newborn screening for CF patients

A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis (CF) patients.

BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review

A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.

UCSD: Medication education can help patients with diabetes better stick to drug treatment plans

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans.

Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy

Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.

Read more Medical News

› Verified 9 days ago